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Lethal mutagenesis or virus transition into error catastrophe is an antiviral strategy that aims at extin-
guishing a virus by increasing the viral mutation rates during replication. The molecular basis of lethal
mutagenesis is largely unknown. Previous studies showed that a critical substitution in the foot-and-mouth
disease virus (FMDV) polymerase was sufficient to allow the virus to escape extinction through modulation of
the transition types induced by the purine nucleoside analogue ribavirin. This substitution was not detected in
mutant spectra of FMDV populations that had not replicated in the presence of ribavirin, using standard
molecular cloning and nucleotide sequencing. Here we selectively amplify and analyze low-melting-temperature
cDNA duplexes copied from FMDV genome populations passaged in the absence or presence of ribovirin
Hypermutated genomes with high frequencies of A and U were present in both ribavirin -treated and untreated
populations, but the major effect of ribavirin mutagenesis was to accelerate the occurrence of AU-rich mutant
clouds during the early replication rounds of the virus. The standard FMDV quasispecies passaged in the
absence of ribavirin included the salient transition-modulating, ribavirin resistance mutation, whose frequency
increased in populations treated with ribavirin. Thus, even nonmutagenized FMDV quasispecies include a
deep, mutationally biased portion of sequence space, in support of the view that the virus replicates close to the
error threshold for maintenance of genetic information.
Lethal mutagenesis is a new antiviral strategy consisting of
driving virus toward extinction due to the occurrence of an
excess of mutations during viral replication. Many cell culture
and some in vivo experiments have provided ample support for
the extinction of viruses upon replication in the presence of
mutagenic nucleoside analogues (reviewed in references 4, 14,
and 32). Quasispecies theory and other theoretical treatments
support the concept that enhanced mutagenesis can result in
virus extinction (3, 7, 8, 20, 48, 63, 71).
The molecular events that lead to loss of virus infectivity by
enhanced mutagenesis are only partially understood, and the
possible participation of hypermutated genomes is unknown.
Previous experimental and in silico studies suggested that un-
der limited mutagenesis a class of defective interfering ge-
nomes termed “defectors” can be generated during viral rep-
lication and that they can interfere with the replication of
standard virus, contributing to extinction (34, 38, 44, 58). These
observations add to an increasing wealth of evidence that in-
dicates that opposite complementing or interfering interac-
tions among components of the mutant spectrum of viral qua-
sispecies can be a determinant of relevant viral traits such as
fitness and virulence (10, 12, 30, 34, 43, 50, 58, 75; reviewed in
reference 57). In this view, when the intensity of the mutagen-
esis increases, overt lethality supersedes interfering interac-
tions, leading to the replicative collapse of the virus. According
to the experimental results, the main determinants of viral
extinction are the intensity of mutagenesis, low viral load, and
low viral fitness (2, 52, 55, 65). Elucidation of the molecular
events that underlie virus extinction by lethal mutagenesis has
been hampered by the limited number of genomes that can be
sequenced from a viral quasispecies by the standard molecular
cloning and Sanger sequencing procedures. Only the most fre-
quent mutant genomes are sampled, and minority genomes
whose nucleotide sequence may deviate from the consensus
sequence or that may contain biased mutation types (hyper-
mutated genomes) go unnoticed. The absence of hypermu-
tated genomes has been taken as evidence against a meltdown
of genetic information and as a disproof of error catastrophe
(67).
One of the model systems used to study lethal mutagenesis has
involved the picornavirus foot-and-mouth disease virus (FMDV)
and the mutagenic nucleoside analogue ribavirin (1--D-ribofura-
nosyl-1-H-1,2,4-triazole-3-carboxamide) (reviewed in reference
17). Ribavirin could drive FMDV toward extinction during virus
replication in cell culture, and extinction was accompanied by an
increase in the frequency of G3A and C3U transitions (1, 2, 54,
64). An increase in the mutation frequency of G3A and C3U
relative to other transition types was relevant to viral extinction, as
suggested by the isolation of a ribavirin-resistant FMDV triple-
polymerase mutant (that included substitutions P44S, P169S, and
M296I) whose major phenotype is to avoid an excess of G3A
and C3U transitions without modification of the average muta-
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FIG. 1. Extinction of FMDV by ribavirin. A total of 2  106 BHK-21 cells were infected with the FMDV WT (progeny of pMT28 transcripts,
termed p0; see Materials and Methods) at a multiplicity of infection (MOI) of about 0.3 PFU/cell. For successive passages, the same number of
cells was infected with 200 l of the supernatant from the previous passage. (A) Infectivity, viral RNA molecules, and specific infectivity in the
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tion frequency (1). The critical amino acid substitution that sup-
pressed the occurrence of the excess G3A and C3U transitions
promoted by ribavirin was P44S, which affects a highly conserved
P residue located at a loop between 2 and 2 of the FMDV
polymerase (1, 26). In the absence of this substitution, replication
in the presence of ribavirin gives rise to deleterious G3A and
C3U transitions, including stop codons (1). How the critical
mutation that leads to the P44S extinction-escape substitution
became dominant in the mutant spectrum of FMDV passaged in
the presence of ribavirin is not known.
Here we report the selective amplification by differential
DNA denaturation PCR (3D-PCR) and nucleotide sequencing
of AU-rich genomes in FMDV populations passaged in the
absence or the presence of ribavirin. Both populations in-
cluded a broad repertoire of hypermutated genomes, and the
main consequence of ribavirin mutagenesis was to enhance the
biased, hypermutated repertoire at early stages of viral repli-
cation with the presence of genomes harboring lethal muta-
tions. Penetration into minority components of the mutant
spectrum has also revealed that substitution P44S in the
FMDV polymerase was represented in the FMDV quasispe-
cies not subjected to ribavirin mutagenesis and increased in
frequency as the population was confronted with ribavirin. The
results have unveiled a hitherto unknown complexity of a viral
mutant spectrum subjected or not subjected to mutagenesis
and the presence of hypermutated viral genomes during tran-
sition toward extinction.
MATERIALS AND METHODS
Cells and viruses. The origin of BHK-21 cells and procedures for cell growth
in Dulbecco’s modified Eagle’s medium (DMEM) and for plaque assays in
semisolid agar medium have been previously described (16, 66). The viruses used
in the experiments are as follows. FMDV C-S8c1 is a plaque-purified derivative
of serotype C isolate C1 Santa Pau-Sp70 (66). An infectious clone of FMDV
C-S8c1, termed pMT28, was constructed by inserting cDNA of FMDV C-S8c1
into a pGEM-1 plasmid, as described previously (28, 72). Thus, FMDV pMT28
used in the experiments is the progeny of infectious transcripts that express the
standard FMDV C-S8c1. To control for the absence of contamination, mock-
infected BHK-21 cells were cultured and their supernatants were titrated in
parallel with the infected cultures; no signs of infectivity or cytopathology in the
cultures or in the control plaque assays were observed in any of the experiments.
Treatment with ribavirin. A solution of ribavirin in phosphate-buffered saline
(PBS) was prepared at a concentration of 100 mM, sterilized by filtration, and
stored at 70°C. Prior to use, the stock solution was diluted in DMEM to reach
the desired ribavirin concentration. For infections in the presence of ribavirin,
cell monolayers were pretreated during 7 h with 5 mM ribavirin prior to infec-
tion. FMDV C-S8c1 was passaged serially in the absence or presence of ribavirin
(5 mM). Incubation of confluent BHK-21 cell monolayers (as used for the
infections for FMDV) with 5 mM ribavirin for 31 h resulted in cell viabilities of
40% to 50%, as determined with trypan blue exclusion (range calculated in six
different determinations). These values, together with the fact that ribavirin-
resistant mutants multiply in BHK-21 cells in the presence of 5 mM ribavirin (1),
indicate that toxicity of ribavirin for the cells cannot account for FMDV extinc-
tion (54). After addition of FMDV and washing of the cell monolayers, the
infection was allowed to proceed in the presence of the same concentration of
ribavirin. For each passage, 2  106 BHK-21 cells were infected with supernatant
of virus from the previous passage (0.2 ml), and the infection continued for about
24 h. The multiplicities of infection (MOI) ranged from 5  106 to 1  101
PFU/cell, and the MOI for each passage can be calculated from the infectivity
values given for each experiment (Fig. 1). Infections in the absence of ribavirin
and mock-infected cells were maintained in parallel; no evidence of contamina-
tion of cells with virus was observed at any time.
Assessment of FMDV extinction. FMDV was considered extinct when no virus
infectivity was detected and no viral RNA was amplified employing a highly
sensitive reverse transcription-PCR (RT-PCR) protocol, either from the super-
natant of the cell culture that harbors the putatively extinguished virus or after
3 blind passages of the cell culture supernatants in BHK-21 cells in the absence
of any drug. Multiple highly sensitive RT-PCR amplification reactions that yield
short cDNAs were carried out to ascertain extinction. These criteria to consider
FMDV extinct are those that we have previously described (2, 52, 53, 64, 65). It
should be noted that infectivity below the level of detection did not necessarily
imply extinction (Fig. 1).
Transcription of viral RNA. Plasmid pMT28 DNA was linearized by cleavage
with the appropriate restriction enzymes as previously described (58). Then the
plasmid was purified by Wizard PCR Preps DNA purification resin (Promega)
and dissolved in RNase-free water. FMDV RNA was transcribed from the
linearized plasmid by using the Riboprobe in vitro transcription system (Pro-
mega). The mixture contained transcription buffer (Promega), 10 mM dithio-
threitol, 0.48 U/l RNasin, 1 mM (each) the standard ribonucleoside triphos-
phates, 4 ng/l linearized plasmid DNA, and 0.3 or 0.4 U/l SP6 or T7 RNA
polymerase; it was incubated for 2 h at 37°C. The RNA concentration was
estimated by agarose gel electrophoresis, with known amounts of rRNA as a
marker.
RNA extraction and quantification of FMDV RNA. Viral RNA was extracted
from the medium of infected cells using TRIzol (Invitrogen) as previously de-
scribed (22). Real-time quantitative RT-PCR was carried out using the Light
Cycler RNA Master SYBR green I kit (Roche), according to the instructions of
the manufacturer and as described previously for FMDV RNA (22). The 2C
coding region was amplified using as primers oligonucleotide 2CR2 (5-GGCA
AACCCTTCAGCAGTAAG; sense orientation [the 5 nucleotide corresponds
to genomic residue 4924]) and oligonucleotide 2CD3 (5-CGCTCACGTCGAT
GTCAAAGTG; antisense orientation [the 5 nucleotide corresponds to genomic
residue 5047]). Quantification was relative to a standard curve obtained with
known amounts of FMDV RNA, synthesized by in vitro transcription of FMDV
cDNA (plasmid pMT28). The specificity of the reaction was monitored by de-
termining the denaturation curve of the amplified DNAs. Negative controls
(without template RNA and RNA from mock-infected cells) were run in parallel
with each amplification reaction, to ascertain the absence of contamination with
undesired templates.
PCR amplification, cloning, and sequencing. Reverse transcription was per-
formed with murine leukemia virus (MLV) reverse transcriptase (Invitrogen), as
specified by the manufacturer. Mutated genomes were recovered using differ-
ential DNA denaturation PCR (3D-PCR) in a two-round procedure. The first
round involved standard amplification: the reaction parameters were 95°C for 5
min, followed by 35 cycles of 95°C for 1 min, 55°C for 30 s, and 72°C for 30 s, and
finally 10 min at 72°C. Residues 6610 to 7071 of the polymerase coding region
were amplified using as primers oligonucleotide A2SacI (5-CACACATCGAC
CCTGAACCGCACCACGA; sense orientation [the 5 nucleotide corresponds
to genomic residue 6581]) and oligonucleotide AV4 (5-TTCTCTTTTCTCCA
TGAGCTT; antisense orientation [the 5 nucleotide corresponds to genomic
residue 7071]). Amplification products were analyzed by agarose gel electropho-
resis using Smart Ladder DNA (Eurogentec) as the molar mass standard. Neg-
supernatants of BHK-21 cells infected with FMDV WT, in the absence (R) or presence (R) of ribavirin (5 mM). Titrations and measurements
of FMDV RNA by quantitative RT-PCR were carried out in triplicate, and mean values are given. The horizontal discontinuous lines indicate the
limit of the detection of infectivity and viral RNA. Procedures for titration of virus infectivity and quantification of FMDV RNA, criteria to
consider FMDV extinct, and the positive and negative controls included in the assays are described in Materials and Methods. (B) RT-PCR
amplifications used to detect viral RNA in the cell culture supernatants to monitor virus extinction. The treatment with ribavirin and passage
number are indicated. The presence or absence of a visible band of 490 bp after RT-PCR amplification indicates extinction (no band) or not
(presence of the band). M, molecular size markers (Smart Ladder DNA [Eurogentec], with the corresponding size in base pairs indicated on the
left). C, negative control, amplification without RNA. Conditions of the infections, mutagenic treatment, determination of infectivity, quanti-
fication of FMDV RNA, and RT-PCR amplification are detailed in Materials and Methods.
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ative controls (amplifications in the absence of RNA) were included in parallel
to ascertain absence of contamination by template nucleic acids.
3D-PCR was performed in the second round of amplification using the equiv-
alent of 0.1 l of the first-round reaction mixture as input. It was carried out
using an Eppendorf gradient Mastercycler S programmed to generate 6°C and
2.6°C gradients in the denaturation temperature. The gradient cycler conditions
were from 84°C to 90°C for 5 min, followed by 35 cycles of 84°C to 90°C for 1 min,
50°C for 30 s, and 72°C for 30 s, and finally 10 min at 72°C. Residues 6610 to 6839
of the polymerase coding region were amplified using as primers oligonucleotide
53D (5-GGGTTGATCGTTGATACCAGAGA; sense orientation [the 5 nu-
cleotide corresponds to genomic residue 6610]) and oligonucleotide AV8 (5-C
AGCGGCGGAACAGCGCT; antisense orientation [the 5 nucleotide corre-
sponds to genomic residue 6839]). The first round gave a 490-bp product, while
the second round yielded a 229-bp fragment. The enzyme used for PCR and the
3D-PCR amplification was BioTaq DNA polymerase (Bioline). PCR products
were purified from agarose gels and ligated into the TOPO TA cloning vector
(Invitrogen, France). After transformation of Top10 Blue cells, up to 50 clones
were analyzed. Sequencing was performed using BigDye Terminator V1.1 (Ap-
plied Biosystems).
RESULTS
Diving into the mutant spectrum of FMDV by selective am-
plification of minority genomes. A recently developed proce-
dure that can be applied to the isolation and sequencing of
components of a mutant spectrum is differential DNA dena-
turation PCR (3D-PCR) (70). It consists of the selective am-
plification of AU-rich genomic RNA mutants by modulating
the denaturation temperatures (Td) during PCR amplification.
3D-PCR has been successfully used to retrieve AU- or AT-rich
molecules from viral or cellular genome populations (68–70,
74), in particular in the amplification of G3A hypermutants
(24, 29, 36, 59, 61, 70, 73, 74).
Passage of FMDV in BHK-21 cells in the presence of 5 mM
ribavirin led to a decrease of virus titer and viral RNA mole-
cules that resulted in diminished specific infectivity and virus
extinction at passage 6 (p6) (Fig. 1A). Extinction was evi-
denced by loss of infectivity and of viral RNA amplifiable by
RT-PCR under standard amplification conditions, which were
not recovered upon blind passage of the virus in the absence of
the drug (1, 54, 56) (Fig. 1B). To analyze the mutant spectrum
of FMDV with regard to genomes enriched in AU as a result
of the mutagenic activity of ribavirin, the FMDV populations
at passages 0 to 5 (p0 to p5, respectively) in the absence or
presence of ribavirin were subjected to 3D-PCR. A DNA copy
(plasmid pMT28, which expresses wild-type FMDV) (72) and
RNA from the initial virus population (p0) were used to de-
termine the denaturation temperature (Td) range at which
residues 6610 to 6839—which encode amino acids 1 to 77 of
the viral polymerase and thus include the critical ribavirin-
resistance substitution P44S—could be amplified, yielding an
amplification product of 229 bp (numbering of genomic resi-
dues according to reference 21). The tests (described in Ma-
terials and Methods) showed that a Td of 89.7°C was the
minimal Td that yielded a positive amplification with RNA
from the initial FMDV population (Fig. 2A). In the absence of
ribavirin, amplification at lower temperatures was observed
(from band 0 at 89.7°C at p0 to bands 2b to 5b at 88.4°C at
passages 2 to 5, respectively) (Fig. 2A and B). A Td of 88.4°C
was the minimal temperature that yielded a positive 3D-PCR
amplification band using as template FMDV RNA from the
viral populations passaged either in the absence or presence of
ribavirin (Fig. 2B, DNA bands labeled with b). Interestingly, in
the presence of ribavirin, an amplification band was obtained
at 88.4°C at p1, but not at subsequent passages, suggesting that
a class of low-melting-temperature DNA was present after one
passage in the presence of ribavirin, but not at later passages
(compare bands labeled in red in Fig. 2B, and the overall
pattern of amplifications in Fig. 2C).
Nucleotide sequences reveal a dynamics of hypermutated
sequences. To determine the nucleotide sequence of the
FMDV polymerase coding region in the RNA that was ampli-
fied by 3D-PCR, DNA from bands 0, 1a to 5a, and 2b to 5b
(which correspond to populations passaged in the absence of
ribavirin) and bands 1a to 5a and 1b (which correspond to
populations passaged in the presence of ribavirin) (Fig. 2B)
were subjected to molecular cloning and sequencing. For the
initial FMDV population (p0), the analysis was performed with
the DNA amplified with a Td of 89.7°C (Fig. 2A). The char-
acterization of the populations passaged in the absence of
ribavirin indicated an increase of mutation frequency and
Shannon entropy of the DNAs with Td of 88.4°C relative to
DNAs with a Td of 89.1°C for passages 2, 3, and 4 (Table 1).
These increases were statistically significant for passages 2, 3,
and 4 (P  0.0001, 	2 test). The maximum mutation frequency
was attained at passage 4 and reached 13.1  103 substitu-
tions per nucleotide (nt). At passage 5, the DNA amplified at
both Td showed a similar mutant spectrum complexity. In the
cases in which an increase of complexity at the low Td was
observed, it was associated with a statistically significant in-
crease of the frequency of transitions G3A and C3U (P 
0.0001, 	2 test) (Table 1).
The characterization of the populations passaged in the
presence of ribavirin yielded a totally different picture (Table
2). A DNA amplified with a Td of 88.4°C was obtained for
passage 1, but not for subsequent passages (Fig. 2B). The
maximum mutant spectrum complexity was attained at this
passage and temperature, again with a statistically significant
increase of transitions G3A and C3U over other mutation
types (P  0.0001, 	2 test). The presence of a band amplified
with a Td of 88.4°C from RNA at passage 1 and its absence in
subsequent passages suggest an initial increased expansion of
sequence space toward genomes enriched in AU and a subse-
quent modification of the mutant spectrum away from such a
portion of sequence space (Table 2).
The mutational spectrum of the different populations
(Fig. 3) suggests diversification of the AU-rich region of
sequence space upon passage of FMDV in the absence of
ribavirin (absence of a band at Td of 88.4°C at passage 1 and
comparable complexity of DNA with Td of 88.4°C and
89.1°C at passage 5). The distribution of mutations per clone
(Fig. 4) indicates that at Td of 88.4°C, most clones include
two or more mutations, and at a Td of 89.1°C, the highest
number of mutations per clone was observed at passage 5. In
contrast, upon passage in the presence of ribavirin, the
initial but transient expansion of the mutant spectrum is
reflected in the absence of amplification bands at a Td of
88.4°C at passages 2, 3, 4, and 5 (Fig. 3). However, genomes
harboring 5, 6, and 8 mutations in the polymerase genomic
region under analysis (which represent mutation frequen-
cies of 2.6  102, 3.1  102, and 4.2  102 substitutions/
nt, respectively) were found only in the population at pas-
sage 3 but not at early passages (Fig. 4B). The DNAs
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obtained with a Td of 89.1°C (bands 1a to 5a in the “plus
ribavirin” branch of Fig. 2B) were reamplified using a Td
range of 86.4°C to 89.0°C (Fig. 5). The presence or absence
of an amplification DNA band and the distribution of mu-
tation types show a unique population of genomes selec-
tively amplified at Td of 86.8°C and 87.3°C for the popula-
tion passaged 3 times in the presence of ribavirin (Fig. 5 and
6; see Tables S5 and S6 in the supplemental material). The
FIG. 2. Amplification of FMDV RNA by 3D-PCR at different denaturation temperatures. (A) 3D-PCR amplification of RNA from FMDV at p0
using the indicated denaturation temperatures (Td) spanning a 6°C interval (from 84.0°C to 90.0°C); 0 indicates the minimum temperature at which a band
of the expected size (229 bp) was obtained. (B) 3D-PCR amplification using the indicated Td (from 84.0°C to 90.0°C) and RNA from the FMDV
populations at passages 1 to 5, in the absence (R) or presence (R) of 5 mM ribavirin. M, molecular size markers as described in the legend to Fig.
1. DNA sizes in base pairs are indicated on the right. p followed by a number indicates the passage number. The DNA bands amplified at the indicated
temperatures are labeled with a number that corresponds to the passage number followed by a or b. They have been used for further analysis, as described
in the text. (C) Schematic representation of the results shown in panel B for easier identification of the positive amplifications at different temperatures
and passage number. Procedures for RNA extraction and 3D-PCR are described in Materials and Methods.
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analyses indicate a complex, nonlinear variation of mutant
spectrum complexity of FMDV populations passaged in the
presence of ribavirin.
In contrast to the rescuing of AU-rich genomes by 3D-PCR,
a sequence analysis of DNA amplified by standard RT-PCR
yielded sequences with a lower frequency of A and U (see Fig.
S1 in the supplemental material).
Shifts in mutant repertoire as a result of ribavirin treat-
ment. A critical ribavirin resistance mutation is present in the
absence of ribavirin selection. The selective amplification of
low-melting-temperature DNA copies of FMDV RNA by vir-
tue of their base composition offered an opportunity to com-
pare the numbers and types of amino acid substitutions in a
unique portion of sequence space of FMDV passaged in the
absence or presence of ribavirin (Fig. 7A). The complete list of
mutations and deduced amino acid substitutions for all popu-
lations analyzed (reamplifications excluded) is given in Tables
S1 and S2 in the supplemental material for populations pas-
saged in the absence of ribavirin and Tables S3 and S4 in the
supplemental material for populations passaged in the pres-
ence of ribavirin. Examination of the repertoire of amino acid
susbtitutions shows that out of a total of 191 different substi-
 
 
FIG. 3. Types of mutations in the genomes of FMDV populations selectively amplified by 3D-PCR. The passage history of the FMDVs and
the amplified DNAs analyzed are given in Fig. 1 and 2A and B. The denaturation temperature used in each 3D-PCR amplification (Td) is indicated
at the top of the boxes; n indicates the number of nucleotides sequenced, and p indicates the passage number in either the absence (R) or
presence (R) of ribavirin. The highlighted numbers and letters next to each box (1a to 5b) correspond to the DNA bands shown in the
electrophoreses of Fig. 2B. Lack of a band indicates that no amplification band was detected. The total numbers of nucleotides sequenced were
78,813 for R and 66,528 for R. The characterization of the complexity of mutant spectra is summarized in Tables 1 and 2. Procedures for
RT-PCR and 3D-PCR amplifications and for nucleotide sequencing are described in Materials and Methods.
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tutions scored, 153 were present in populations passaged in the
absence of ribavirin, of which 57 (29.8% of the total) were
found exclusively in populations passaged in the absence of
ribavirin. A total of 134 amino acid substitutions were present
in the populations passaged in the presence of ribavirin, of
which 38 (19.9% of the total) were found exclusively in the
populations passaged in the presence of ribavirin. Despite the
unavoidable limitation in the number of sampled sequences (a
total of 145,341 nucleotides from 15 3D-PCR-amplified
DNAs), the results show that 50% of the total number of
amino acid substitutions in the polymerase are shared by
FMDV populations passaged in the absence and presence of
ribavirin (see Tables S1 to S4 in the supplemental material).
Thus, there is a remarkable overlap in the sequence space
occupied in the absence and presence of ribavirin.
Passages in the presence and absence of ribavirin did not
result in significant differences regarding the total number of
amino acid substitutions relative to the number of nucleotides
sequenced (6.8  103 and 6.2  103, respectively) or in the
frequency of substitutions with lower, equal, or higher accept-
ability (i.e., 0,  0,  0, according to the PAM250 probability
matrix [25]) (P  0.79, P  0.85, and P  0.72, respectively; 	2
test). Interestingly, some amino acid substitutions increased
significantly in the presence of ribavirin, including the critical
ribavirin resistance substitution P44S (1). P44S was amply rep-
resented in the DNA amplified from passage 1 (Td  88.4°C,
10 clones; Td  89.1°C, 1 clone), passage 2 (Td  89.1°C, 1
clone), and passage 3 (Td  89.1°C, 6 clones) in the presence
of ribavirin (see Tables S3 and S4 in the supplemental mate-
rial). However, P44S was also present in DNA amplified from
populations passaged in the absence of ribavirin at passage 1
(Td  89.1°C, 2 clones), passage 3 (Td  88.4°C, 3 clones; Td 
89.1°C, 1 clone), and passage 5 (Td  89.1°C, 3 clones) (see
Tables S1 and S2 in the supplemental material) (overview in
Fig. 7A). The preexistence of ribavirin resistance mutations in
populations not treated with ribavirin adds to evidence of the
presence of phenotypically relevant mutations in mutant spec-
tra of RNA viruses even in the absence of selection for that
phenotype (see Discussion). The quantification of the number
of amino acid substitutions as a function of passage number in
the absence or presence of ribavirin (Fig. 7B) reflects a dy-
namics of amino acid changes that mirrors the dynamics of the
total mutation types (compare Fig. 3 and 7B). In particular, the
increase of genetic complexity at passage 1, which is a hallmark
of ribavirin treatment, has a parallel in the number of amino
acid substitutions. Thus, the selective amplification of minority
FMDV genomes rich in A and U suggests the presence of an
ample repertoire of amino acid substitutions, with a significant
overlap between populations passaged in the absence and pres-
ence of ribavirin, and a disparate evolution of phenotypic space
in the absence and presence of ribavirin.
DISCUSSION
The analysis of an AU-rich portion of the genomic sequence
space has unveiled a great mutant spectrum complexity not
only of FMDV populations passaged in the presence of riba-
virin, but also those passaged in its absence. The results con-
firm the depth of mutant spectra in RNA virus populations in
general, previously uncovered using standard molecular and
biological cloning, followed by Sanger sequencing, and further
evidenced by the recent application of ultradeep sequencing,
microarray analysis, or successive amplification methods (13,
18, 27, 41, 45, 57, 76–78).
The present comparison has involved FMDV populations
passaged in BHK-21 cells in the absence of ribavirin, that are
capable of maintaining the viral genetic information for hun-
dreds of passages (23, 28, 51), and populations passaged in the
presence of ribavirin, which are doomed to extinction in a few
passages (1, 56). Contrary to expectations, replication in the
presence of ribavirin did not result in an overall broader mu-
tant repertoire than that in the absence of ribavirin (compare
Fig. 7, Tables 1 and 2, and Tables S1 to S4 in the supplemental
material), despite the 3D-PCR targeting AU-rich genomes and
being G3A and C3U, the mutation types favored by ribavirin
FIG. 4. Overview of the distribution of the number of mutations
per molecular clone in the FMDV populations amplified by 3D-PCR.
The origin of the populations (p0 to p5) passaged in either the absence
(R) or presence (R) of ribavirin and amplified DNAs are given in
Fig. 1 and 2A and B. The distribution of mutation types is shown in Fig.
3. The front axes identify the FMDV populations and the denaturation
temperature (Td) used for each amplification. Procedures are de-
scribed in Materials and Methods.
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during FMDV replication (1, 2, 56, 64). However, several sig-
nificant distinctive features of the evolution of the two popu-
lations became apparent as a result of the comparison of the Td
values at which a positive amplification was observed, and of
the repertoire of mutations in the corresponding populations
(compare Fig. 3 in the absence and presence of ribavirin). This
amplification asymmetry suggests that the initial infection in
the presence of ribavirin produced an expansion in sequence
space toward regions rich in A and U that were not repre-
sented after one passage in the absence of ribavirin. However,
the expanded mutant repertoire could not be maintained de-
spite continuing mutagenesis by ribavirin, presumably due to
negative selection acting on highly mutated AU-rich genomes.
In favor of this interpretation is a previous study using partition
analysis of quasispecies (PAQ) (6) applied to FMDV genomes
amplified by RT-PCR under standard conditions, which indi-
cated a compression of the mutant spectrum after multiple
passages in the presence of ribavirin, following an initial ex-
pansion (49). In the same study, the ratio of nonsynonymous to
synonymous mutations suggested the operation of negative
selection (49). The deleterious effect of a mutational bias in
favor of G3A and C3U was previously evidenced by the fact
that the major phenotype of a ribavirin-resistant mutant con-
sisted of an alteration of ribavirin recognition by the FMDV
polymerase that prevented the accumulation of genomes with
substitutions G3A and C3U (1). The deleterious effect of an
excess of substitutions G3A and C3U is in agreement with
the limited occupation of this portion of sequence space and
the absence of DNA amplification at Td of 88.4°C at passages
2 through 5 in the presence of ribavirin (Fig. 2). Despite the
decline in sequences enriched in AU, sufficient defective ge-
nomes promoted by ribavirin must be present in subsequent
passages to drive the virus toward extinction (Fig. 1). The
analyses have involved residues 9 to 71 of the polymerase
coding region. A comparison of the complexity of mutant spec-
tra of different genomic regions of FMDV and other RNA
viruses subjected to increased mutagenesis (2, 44, 53, 65)
renders it very unlikely that the complexities determined in the
polymerase coding region differ substantially for other
genomic regions.
The dissimilar evolution of genomic complexity in the ab-
sence and presence of ribavirin (Fig. 3) is also observed at the
amino acid level (Fig. 7B), suggesting that it may have conse-
quences for phenotypic evolution, in particular due to a nar-
FIG. 5. Reamplification of FMDV RNA by 3D-PCR at different denaturation temperatures. 3D-PCR reamplification at the indicated Tds
(from 86.4°C to 89.0°C), using as template DNA amplified at a Td of 89.1°C from the populations at passages 1 to 5 in the absence or presence
of ribavirin (bands 1a to 5a shown in Fig. 2B). M, molecular size markers as described in the legend to Fig. 1. DNA size in base pairs is indicated
on the right. p followed by a number indicates the passage number. The DNA bands amplified at the indicated temperatures are labeled with a
number that corresponds to the passage number followed by b, c, d, and e. They have been used for further analysis, as described in the text.
(B) Schematic representation of the results shown in panel A with indication of the positive amplifications at different temperatures and passage
numbers. Procedures for RNA extraction and 3D-PCR are described in Materials and Methods.
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rower repertoire of alternative amino acid sequences available
for adaptation. This underscores those amino acid substitu-
tions that increased in frequency in the presence of ribavirin,
such as P44S, which is responsible for high-level ribavirin re-
sistance in FMDV (1). Substitution P44S does not inflict a
detectable fitness cost upon FMDV (1), and this may explain
its presence in the mutant spectrum of the virus passaged in the
absence of ribavirin. Additional amino acid substitutions
within the amino-terminal region of the FMDV polymerase
analyzed, which have never been found in consensus sequences
or mutant spectra following standard RT-PCR amplification,
were detected in the AU-rich subpopulations (Fig. 7; see Ta-
bles S1 to S4 in the supplemental material). In addition to
P44S, substitutions that were found more than twice in the
absence of ribavirin (suggesting there were no severe negative
effects on fitness) and that increased to the same or a greater
extent than P44S in the presence of ribavirin are P23L 
P23S  A38V  P44S (in order of increase in frequency in the
presence of ribavirin, based on the data of Fig. 7). Substitutions
that followed the same pattern but that were found only twice
in the absence of ribavirin are A37V  V51I  P36L 
P32S  S40F  E54G (Fig. 7). Also potentially relevant is
substitution V55I, found four times in the presence of ribavirin
despite V55 being totally invariant in the absence of ribavirin.
The substitutions that show the highest increases in the pres-
ence of ribavirin are under investigation as possible candidates
to confer resistance to ribavirin. In view of the multiple and
mechanistically different ribavirin resistance mutations de-
scribed for picornaviruses (1, 5, 9, 60, 64, 75), it is tempting to
speculate that RNA viruses may be endowed with several al-
ternative mutational pathways to achieve ribavirin resistance
and that the one chosen depends on the relevant substitutions
being present in hidden minorities of mutant spectra due to
their low or negligible effect on viral fitness. The presence of
the P44S substitution in the mutant spectrum of an FMDV not
treated with ribavirin extends previous evidence of the pres-
ence of inhibitor resistance mutations in natural viral isolates
infecting patients who had never been treated with the corre-
sponding inhibitors (11, 35, 39, 40, 42, 46; reviewed for hepa-
titis C virus [HCV] in reference 62).
The similar complexity (mutation frequency and Shannon
entropy values) scored in the absence and presence of ribavirin
FIG. 6. Types of mutations in the genomes of FMDV populations present in DNA that was reamplified from a specific 3D-PCR product in the
presence of ribavirin. The passage history of the FMDVs and the amplified DNAs analyzed are given in Fig. 1 and 5. The denaturation temperature
(Td) used in each 3D-PCR amplification is indicated at the top of the boxes. n indicates the number of nucleotides sequenced; p indicates the
passage number in the presence (R) of ribavirin. The highlighted numbers and letters above each box (1c, 2b and 2c, 3b to 3e, and 4b) correspond
to the DNA bands shown in the electrophoreses of Fig. 5. Lack of a band indicates that no amplification band was detected. The characterization
of the complexity of mutant spectra is summarized in Table S6 in the supplemental material. Procedures for RT-PCR, 3D-PCR amplifications, and
nucleotide sequencing are described in Materials and Methods.
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FIG. 7. Amino acid substitutions at the RNA-dependent RNA polymerase region of FMDV amplified by 3D-PCR. (A) All amino acid substitutions
deduced from the nucleotide sequences obtained in DNA from the first amplification bands (Fig. 2 and 3 are included). Amino acids 9 to 71 (single-letter code)
have been analyzed (sequence in the black box at the top). Amino acid substitutions scored in the absence or presence of ribavirin have been separated based
on the probability of occurrence according to the PAM250 substitution matrix (25), where 0,  0, and 0 in shades of gray and red represent substitutions
in the absence (R) or presence (R) of ribavirin, respectively. Subindices indicate the number of times that a given amino acid has been found among the viral
population analyzed. Amino acids that correspond to substitutions that occurred at least twice in the absence of ribavirin and that increased to the same or a larger
extent than P44S in the presence of ribavirin have been circled (see text). (B) Evolution of the total number of amino acid substitutions (i.e., those depicted in
panel A) as a function of passage number. Procedures are described in Materials and Methods.
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(Tables 1 and 2) reinforces the concept that the virus replicates
close to an error threshold for maintenance of genetic infor-
mation, as previously suggested from independent approaches
(15, 19, 20, 37). Although sequence heterogeneities of FMDV
within infected animals have been reported (16, 47, 77), it is
not known whether natural isolates of the virus display such a
broad repertoire of genomes with high AU base frequencies.
Despite a claim to the contrary (67), extinction of FMDV by
lethal mutagenesis is a new paradigm in antiviral therapy since
its basic mechanism is not merely a decrease in viral load and
of the R0 value (defined in reference 8) but a melting of genetic
information evoked by mutagenesis that results in a decrease
of R0. The present study has revealed that such a melting is
mediated by an early movement in sequence space toward
highly mutated genomes that precedes a decrease in viral load
and the subsequent extinction. An RNA close to what could
classify as hypermutated genome was detected in a previous
analysis of lymphocytic choriomeningitis virus (LCMV) sub-
jected to 5-fluorouracil mutagenesis (33). However, a shift in
sequence space was not noticed using previous approaches
based on standard biological or molecular cloning and se-
quencing. Movements in sequence space may be a relevant
ingredient in the transition toward error catastrophe. An in-
variant consensus sequence may conceal lethal defection by an
early shift in regions of sequence space prone to produce
defector genomes (31, 33, 34).
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